{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:12:46Z","timestamp":1785463966531,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEAF67330003"],"award-info":[{"award-number":["HEAF67330003"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.joim.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:54:00Z","timestamp":1768377240000},"page":"253-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unveiling the antimetastatic activity and molecular mechanism of montanine in lung cancer cells via the integration of network pharmacology approaches with in vitro and in vivo investigations"],"prefix":"10.1016","volume":"24","author":[{"given":"Iksen","family":"Iksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsaranyatron","family":"Singharajkomron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausana","family":"Wongtayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onsurang","family":"Wattanathamsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Choonhapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sureeporn","family":"Wademonkolgorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien Minh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trang Huyen","family":"Xuan Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoai Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varisa","family":"Pongrakhananon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"issue":"13","key":"10.1016\/j.joim.2026.01.001_b0010","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.3390\/molecules26134100","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway in lung cancer: an update regarding potential drugs and natural products","volume":"26","author":"Iksen","year":"2021","journal-title":"Molecules"},{"issue":"30","key":"10.1016\/j.joim.2026.01.001_b0015","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.12998\/wjcc.v10.i30.10882","article-title":"Clinical characteristics and prognosis of non-small cell lung cancer patients with liver metastasis: a population-based study","volume":"10","author":"Wang","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.joim.2026.01.001_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.731788","article-title":"EMT mechanism, lung cancer metastasis, and microRNA","volume":"8","author":"Tanabe","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.joim.2026.01.001_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111450","article-title":"The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges","volume":"138","author":"Xie","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"26","key":"10.1016\/j.joim.2026.01.001_b0035","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1038\/sj.onc.1210172","article-title":"A chemical biology approach identifies a \u03b2-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1\/Mek-1\/Erk1\/2 pathway","volume":"26","author":"Carie","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0040","doi-asserted-by":"crossref","first-page":"15994","DOI":"10.1038\/s41598-022-19991-y","article-title":"ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinoma","volume":"12","author":"Ji","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/13880209.2022.2069823","article-title":"Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by downregulating ADRB2 expression","volume":"60","author":"Lu","year":"2022","journal-title":"Pharm Biol"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cas.14670","article-title":"Activation of \u03b22-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells","volume":"112","author":"Sakakitani","year":"2021","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.joim.2026.01.001_b0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-023-04586-9","article-title":"The \u03b22-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models","volume":"92","author":"Jablo\u00f1ski","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.joim.2026.01.001_b0060","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cellsig.2015.02.012","article-title":"Activation of \u03b22-adrenergic receptor by (R,R\u2032)-4\u2032-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells","volume":"27","author":"Wnorowski","year":"2015","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.joim.2026.01.001_b0065","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204370","article-title":"Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases","volume":"41","author":"Zheng","year":"2021","journal-title":"Biosci Rep"},{"issue":"10","key":"10.1016\/j.joim.2026.01.001_b0070","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3390\/molecules25102337","article-title":"Chemical and biological aspects of montanine-type alkaloids isolated from plants of the Amaryllidaceae family","volume":"25","author":"Koutov\u00e1","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.joim.2026.01.001_b0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11101-020-09675-8","article-title":"The Amaryllidaceae alkaloids haemanthamine, haemanthidine and their semisynthetic derivatives as potential drugs","volume":"20","author":"Cahl\u00edkov\u00e1","year":"2021","journal-title":"Phytochem Rev"},{"issue":"10","key":"10.1016\/j.joim.2026.01.001_b0080","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.phymed.2007.12.001","article-title":"Screening for cytotoxic activity of extracts and isolated alkaloids from bulbs of Hippeastrum vittatum","volume":"15","author":"Silva","year":"2008","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.joim.2026.01.001_b0085","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0090","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad518","article-title":"Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0095","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41598-023-28821-8","article-title":"Identifying molecular targets of aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments","volume":"13","author":"Iksen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.joim.2026.01.001_b0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11094-022-02666-3","article-title":"Quantitative determination of 2-methoxypancracine in Hippeastrum reticulatum bulbs by HPLC-DAD","volume":"56","author":"Hoang","year":"2022","journal-title":"Pharm Chem J"},{"issue":"9","key":"10.1016\/j.joim.2026.01.001_b0105","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires DE","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.joim.2026.01.001_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0115","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1038\/s41598-021-85675-8","article-title":"Erianthridin suppresses non-small-cell lung cancer cell metastasis through inhibition of Akt\/mTOR\/p70S6K signaling pathway","volume":"11","author":"Pothongsrisit","year":"2021","journal-title":"Sci Rep"},{"issue":"W1","key":"10.1016\/j.joim.2026.01.001_b0120","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.joim.2026.01.001_b0125","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0130","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"issue":"D1","key":"10.1016\/j.joim.2026.01.001_b0135","doi-asserted-by":"crossref","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","article-title":"OMIM.org: leveraging knowledge across phenotype-gene relationships","volume":"47","author":"Amberger","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: therapeutic target database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.joim.2026.01.001_b0145","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.joim.2026.01.001_b0150","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"10.1016\/j.joim.2026.01.001_b0155","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"10","key":"10.1016\/j.joim.2026.01.001_b0160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"issue":"D1","key":"10.1016\/j.joim.2026.01.001_b0165","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.joim.2026.01.001_b0170","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1021\/acsptsci.3c00046","article-title":"Preclinical characterization of 22-(4\u2032-pyridinecarbonyl) jorunnamycin a against lung cancer cell invasion and angiogenesis via AKT\/mTOR signaling","volume":"6","author":"Iksen","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.joim.2026.01.001_b0180","article-title":"Current treatments for non-small cell lung cancer","volume":"12","author":"Guo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.joim.2026.01.001_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2026.01.001_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115295","article-title":"Antiproliferative activity and apoptosis-inducing mechanism of Amaryllidaceae alkaloid montanine on A549 and MOLT-4 human cancer cells","volume":"166","author":"Koutova","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2026.01.001_b0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fonc.2020.00499","article-title":"EMT factors and metabolic pathways in cancer","volume":"10","author":"Georgakopoulos-Soares","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.joim.2026.01.001_b0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2007-0198TR","article-title":"Alveolar epithelial \u03b22-adrenergic receptors","volume":"38","author":"Mutlu","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.joim.2026.01.001_b0205","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jcph.1443","article-title":"\u03b22-Adrenergic receptor gene affects the heart rate response of \u03b2-blockers: evidence from 3 clinical studies","volume":"59","author":"Shahin","year":"2019","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.joim.2026.01.001_b0210","first-page":"147","article-title":"Activation of adrenergic receptor \u03b22 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma","volume":"41","author":"Liu","year":"2018","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.joim.2026.01.001_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101117","article-title":"\u03b22-Adrenergic pathway activation enhances aggressiveness and inhibits stemness in head and neck cancer","volume":"14","author":"Lopes-Santos","year":"2021","journal-title":"Transl Oncol"},{"issue":"18","key":"10.1016\/j.joim.2026.01.001_b0220","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.3390\/molecules27185940","article-title":"\u03b22-Adrenergic receptor signaling pathway stimulates the migration and invasion of cancer cells via Src activation","volume":"27","author":"Jeong","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.joim.2026.01.001_b0225","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2174\/1568009617666170330151415","article-title":"The \u03b22-adrenergic agonist salbutamol inhibits migration, invasion and metastasis of the human breast cancer MDA-MB-231 cell line","volume":"17","author":"Rivero","year":"2017","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.joim.2026.01.001_b0230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mc.22091","article-title":"Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells","volume":"54","author":"Zimmerman","year":"2015","journal-title":"Mol Carcinog"},{"issue":"4","key":"10.1016\/j.joim.2026.01.001_b0235","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/mc.22598","article-title":"Adenylyl cyclase 3\/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cells","volume":"56","author":"Quinn","year":"2017","journal-title":"Mol Carcinog"},{"issue":"7","key":"10.1016\/j.joim.2026.01.001_b0240","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1007\/s13277-015-4717-z","article-title":"The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells","volume":"37","author":"Unahabhokha","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.joim.2026.01.001_b0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fphar.2018.00054","article-title":"The A2B adenosine receptor modulates the epithelial\u2013mesenchymal transition through the balance of cAMP\/PKA and MAPK\/ERK pathway activation in human epithelial lung cells","volume":"9","author":"Giacomelli","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2026.01.001_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2020.104865","article-title":"\u03b2 Adrenergic receptor activation inhibits oral cancer migration and invasiveness","volume":"118","author":"Bravo-Calder\u00f3n","year":"2020","journal-title":"Arch Oral Biol"},{"issue":"12","key":"10.1016\/j.joim.2026.01.001_b0255","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.21037\/tcr-21-1257","article-title":"ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironment","volume":"10","author":"Wei","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"2","key":"10.1016\/j.joim.2026.01.001_b0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14715\/cmb\/2024.70.2.17","article-title":"Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR\/PI3K\/AKT signaling pathway in lung adenocarcinoma","volume":"70","author":"Zhou","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-Grand)"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496426000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496426000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:28:44Z","timestamp":1778837324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496426000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2095496426000014"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2026.01.001","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the antimetastatic activity and molecular mechanism of montanine in lung cancer cells via the integration of network pharmacology approaches with in vitro and in vivo investigations","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}